Singapore’s Tessa raises $80M for T cell therapy push – FierceBiotech
FierceBiotech |
Singapore's Tessa raises $80M for T cell therapy push
FierceBiotech The VST approach has some similarities with autologous CAR–T therapies, and involves harvesting white blood cells from peripheral blood, stimulating them to proliferate and respond to tumor cells expressing viral antigens, and then infusing the cells … Parker Institute-allied Tessa grabs an $80M round for its next-gen cancer cell therapies |
